Using tumor organoids to find best drugs for glioblastoma
Part of Cancer clinical trials.
This trial uses a sample of your tumor removed during surgery to grow tiny 3D models (organoids) in a lab. These models help doctors test which drugs might work best for your specific glioblastoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with glioblastoma (a type of brain tumor) and are having surgery to remove it.
- Your tumor is the IDH-wildtype subtype (a standard test can confirm this).
- You have not had chemotherapy or radiation therapy before this surgery.
- The surgery must be a full tumor removal (not a needle biopsy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a lab-grown model of your tumor (called an organoid) to test whether different drugs might work against it. The goal is to find the best treatment for your specific glioblastoma.
This study tests a new way to grow miniature versions of your brain tumor in the lab (called organoids) from a small piece of your tumor removed during surgery. The results may help doctors understand which treatments might work best for you in the future.
This trial tests whether testing drugs on your tumor cells in a lab can help find the best treatment for you. It is for people with a specific type of glioblastoma that has not been treated yet.
This trial studies different treatment regimens for people with glioblastoma that is either newly diagnosed or has come back. It aims to find which treatment approach works best for controlling the tumor and improving outcomes.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This study takes tumor tissue from people having surgery for a certain type of gut or pancreas cancer (neuroendocrine tumors). The tissue is used to grow tiny 3D models called organoids in the lab, which can help researchers learn more about the tumor and find better treatments.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.